High-Dose Intravenous Lipid for Very Preterm or Very Low Birth Weight Infants Effects on Growth
NCT ID: NCT06909929
Last Updated: 2025-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
70 participants
INTERVENTIONAL
2024-09-01
2025-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Prepartum Intravenous Fluid Intake on Newborn Weight Loss in the First Days of Life
NCT07243054
Does Starting Feeds on the First Day of Life Help Premature Infants Reach Full Volume Feeds Sooner?
NCT06731439
Intravenous Fat Emulsions and Premature Infants
NCT01096446
Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants
NCT00833222
The Effect of Caffeine Therapy in Cardiovascular Stability in Preterm Neonates at Assiut University Children Hospital NICU
NCT07274969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2 gram
This group will get 2 g of lipid IV in the early 24 hours of life
Lipid IV 2 g
This group will get 2 g of lipid IV in the early 24 hours of life
1 gram
This group will get 1 g of lipid IV in the early 24 hours of life
lipid IV 1 gram
This group will get 1 g of lipid IV in the early 24 hours of life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lipid IV 2 g
This group will get 2 g of lipid IV in the early 24 hours of life
lipid IV 1 gram
This group will get 1 g of lipid IV in the early 24 hours of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
32 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Putri Maharani Tristanita Marsubrin, MD, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Putri MT Marsubrin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cipto Mangunkusumo Hospital, Jakarta, Central Jakarta 10430
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo Hospital
Jakarta, Central Jakarta, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LIPIP2GVS1G
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.